WST West Pharmaceutical Services, I
Healthcare · Medical Instruments & Supplies
328.20
-7.67%
Sobre la empresa
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Rango 52 semanas
Análisis a fondo del dividendo
West Pharmaceutical Services, I (WST) operates in the Medical Instruments & Supplies sector. The company currently offers a dividend yield of 0.26%. This yield is within its 5-year historical range of 0.18% to 0.33%, with a 5-year average of 0.24%. Yield Theory suggests the stock is currently valued "fairly." No momentum, value, or overall rating scores are provided in the data.
Histórico de dividendos
West Pharmaceutical Services, I has maintained a 28-year dividend increase streak, earning it a "Champion" tier classification. The dividend has grown with a 3-year compound annual growth rate (CAGR) of 5.27% and a 5-year CAGR of 5.59%. At this rate, the dividend would double in approximately 12.9 years. Annual dividends per share have been: 0.40 USD (2014), 0.44 USD (2015), 0.48 USD (2016), 0.52 USD (2017), 0.56 USD (2018), 0.60 USD (2019), 0.64 USD (2020), 0.68 USD (2021), 0.72 USD (2022), 0.76 USD (2023), 0.80 USD (2024), and 0.84 USD (2025).
Quantic · Gratis
Desbloquea el análisis completo
Lectura de la seguridad del dividendo, los riesgos clave y qué vigilar.
Generado por IA a partir de los datos de dividendos de Quantic · Actualizado el 24 Jul 2026 · Información, no asesoramiento financiero.
Se muestra en inglés — la traducción está en camino.
Historial de precios
Perfil de dividendos
Banda de rentabilidad La rentabilidad por dividendo actual de una acción frente a su propio rango de los últimos cinco años — el mínimo, la media y el máximo. Cerca del máximo, las acciones parecen relativamente baratas para los ingresos que pagan; cerca del mínimo, relativamente caras. Es la imagen que hay detrás de la Teoría del Rendimiento por Dividendo. Saber más → (5 años)
Calendario de pagos
Histórico de dividendos
Dividendo por acción por año
Deuda y apalancamiento
Últimas cifras del balance publicadas.
seguido por 1
Aparece en estas listas
WST cumple los criterios de estos rankings de dividendos.
¿Nuevo en la inversión en dividendos?
Información, no asesoramiento financiero.
Quantic · Gratis
Sigue WST y toda tu cartera
Rendimiento real, seguridad del dividendo, ingresos netos de impuestos y tu camino a la libertad — gratis, sin conexión con el bróker.